Inhibition of CCAAT/enhancer binding protein δ expression by chrysin in microglial cells results in anti-inflammatory and neuroprotective effects

Journal of Neurochemistry

Volumn 115, Issue 2, 2010, Pages 526-536

  Gresa Arribas, Núria ^a   Serratosa, Joan ^a   Saura, Josep ^b   Solà, Carme ^a  

^a CSIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Glial activation; In vitro; Neuroinflammation; Neuroprotection; Transcription factor

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN BETA; CCAAT ENHANCER BINDING PROTEIN DELTA; CHRYSIN; CYCLOOXYGENASE 2; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN CELL; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA BINDING; EMBRYO; GENE EXPRESSION; IN VITRO STUDY; MICROGLIA; MOUSE; NERVE CELL NECROSIS; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANIMALS, NEWBORN; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DRUG INTERACTIONS; EMBRYO, MAMMALIAN; FLAVONOIDS; GENE EXPRESSION REGULATION; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICROGLIA; NERVE TISSUE PROTEINS; NEURONS; NF-KAPPA B; TRANSFECTION;

ESCHERICHIA COLI; MURINAE;

EID: 78651284870     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06952.x     Document Type: Article

References (58)

1. Bal-Price A. and Brown G. C. (2001) Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21, 6480-6491.
2. Blasi E., Barluzzi R., Bocchini V., Mazzolla R. and Bistoni F. (1990) Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus. J. Neuroimmunol. 27, 229-237.
3. Brooke S. M., Bliss T. M., Franklin L. R. and Sapolsky R. M. (1999) Quantification of neuron survival in monolayer cultures using an enzyme-linked immunosorbent assay approach, rather than by cell counting. Neurosci. Lett. 267, 21-24.
4. Caivano M., Gorgoni B., Cohen P. and Poli V. (2001) The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein b (C/EBPb) and C/EBPd transcription factors. J. Biol. Chem. 276, 48693-48701.
5. Cardinaux J. R., Allaman I. and Magistretti P. J. (2000) Pro-inflammatory cytokines induce the transcription factors C/EBPb and C/EBPd in astrocytes. Glia 29, 91-97.
6. Chen C. J., Raung S. L., Liao S. L. and Chen S. Y. (2004) Inhibition of inducible nitric oxide synthase expression by baicalein in endotoxin/cytokine- stimulated microglia. Biochem. Pharmacol. 67, 957-965.
7. Chen H., Jacobs E., Schwarzschild M. A., McCullough M. L., Calle E. E., Thun M. J. and Ascherio A. (2005) Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease. Ann. Neurol. 58, 963-967. (Pubitemid 41746889)
8. Cho H., Yun C. W., Park Q. K., Kong J. Y., Kim K. S., Park Y., Lee S. And Kim B. K. (2004) Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivates. Pharmacol. Res. 49, 37-43.
9. Choi S. H., Lee D. Y., Chung E. S., Hong Y. B., Kim S. U. and Jin B. K. (2005) Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J. Neurochem. 96, 1755-1765.
10. Colangelo V., Schurr J., Ball M. J., Bazan G., Palacios Pelaez R. and Lukiw W. J. (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signalling. J. Neurosci. Res. 70, 462-473.
11. Ejarque-Ortiz A., Medina M. G., Tusell J. M., Pérez-Gonzalez A. P., Serratosa J. and Saura J. (2007a) Up-regulation of CCAAT/ enhancer binding protein b in activated astrocytes and microglia. Glia 55, 178-188.
12. Ejarque-Ortiz A., Tusell J. M., Serratosa J. and Saura J. (2007b) CCAAT/enhancer binding protein-a is down-regulated by toll-like receptor agonists in microglial cells. J. Neurosci. Res. 85, 985-993.
13. Ejarque-Ortiz A., Gresa-Arribas N., Straccia M., Mancera P., Solà C., Tussell J. M., Serratosa J. and Saura J. (2010) CCAAT/enhancer binding protein delta in microglial activation. J. Neurosci. Res. 88, 1113-1123.
14. Farfara D., Lifshitz V. and Frenkel D. (2008) Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. J. Cell Mol. Med. 12, 762-780.
15. Frandsen A. and Schousboe A. (1990) Development of excitatory aminoacid induced cytotoxicity in cultured neurons. Int. J. Dev. Neurosci. 8, 209-216.
16. 2 formation in RAW 264.7 cells. J. Nutr. 136, 1517-1521.
17. Jack C., Ruffini F., Bar-Or A. and Antel J. P. (2005) Microglia and multiple sclerosis. J. Neurosci. Res. 81, 363-373.
18. Jiang B., Du J., Liu J.-H., Bao Y.-M. and An L.-J. (2008) Catalpol attenuates the neurotoxicity induced by β-amyloid1-42 in cortical neuron-glia cultures. Brain Res. 1188, 139-147.
19. Lee H., Kim Y. O., Kim H., Kim S. Y., Noh H. S., Kang S. S., Cho G. J., Choi W. S. and Suk K. (2003) Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J. 17, 1943-1944.
20. Lee S. M., Yune T. Y., Kim S. J., Kim Y. C., Oh Y. J., Markelonis G. J. And Oh T. H. (2004) Minocycline inhibits apoptotic cell death via attenuation of TNF-α expression following iNOS/NO induction by lipopolysaccharide in neuron/glia co-cultures. J. Neurochem. 91, 568-578.
21. Li R., Strohmeyer E., Liang Z., Lue L. F. and Rogers J. (2004) CCAAT/ enhancer binding protein delta (C/EBPδ) expression and elevation in Alzheimer's disease. Neurobiol. Aging 25, 991-999.
22. Li F. Q., Wang T., Pei Z., Liu B. and Hong J. S. (2005) Inhibition of microglial activation by the herbal flavonoid baicalein attenuates inflammation-mediated degeneration of dopaminergic neurons. Neural. Transm. 112, 331-347.
23. Liang Y. C., Tsai S. T., Tsai D. C., Lin-Shiau S. Y. and Lin J. K. (2001) Supression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-c by flavonoids in mouse macrophages. FEBS Lett. 496, 12-18.
24. Liu Y. W., Chen C. C., Wang J. M., Chang W. C., Huang Y. C., Chung S. Y., Chen B. K. and Hung J. J. (2007) Role of transcriptional factors Sp1, c-Rel and c-Jun in LPS-induced C/EBPδ gene expression of mouse macrophages. Cell. Mol. Life Sci. 64, 3282-3294.
25. Livak K. J. and Schmittgen T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods 25, 402-408.
26. Lobsiger C. S. and Cleveland D. W. (2007) Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease. Nat. Neurosci. 10, 1355-1360.
27. Lucas S. M., Rothwell N. J. and Gibson R. M. (2006) The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147, S232-S240.
28. Mander P., Borutaite V., Moncada S. and Brown G. C. (2005) Nitric oxide from inflammatory-activated glia synergizes with hypoxia to induce neuronal death. J. Neurosci. Res. 79, 208-215.
29. O'Neill L. A. and Kaltschmidt C. (1997) NF-kappa B: A crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252-258.
30. Pahan K., Jana M., Liu X., Taylor B. S., Wood C. and Fischer S. M. (2002) Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes. J. Biol. Chem. 277, 45984-45991.
31. Pereira M. P., Hurtado O. and Cardenas A. et al. (2006) Rosiglitazone and 15-deoxy-delta(12, 14)-prostaglandin J(2) cause potent neuroprotection alter experimental stroke through noncompletely overlapping mechanisms. J. Cereb. Blood Flow Metab. 26, 218-229.
32. Pérez-Capote K., Serratosa J. and Solà C. (2004) Glial activation modulates glutamate neurotoxicity in cerebellar granule cell cultures. Glia 45, 258-268.
33. Pérez-Capote K., Saura J., Serratosa J. and Solà C. (2006) Expression of C/EBPα and C/EBPβ in glial cells after inducing glial activation by different stimuli. Neurosci. Lett. 410, 25-30.
34. Poli V. (1998) The Role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 273, 29279-29282.
35. Qian L., Xu Z., Zhang W., Wilson B., Hong J.-S. and Flood P. M. (2007) Simomenine, a natural dextrorotatory morphinan analog, is antiinflammatory and neuroprotective through inhibition of microglial NADPH oxidase. J. Neuroinflam. 4, 23-36.
36. Qin L., Liu Y., Cooper C., Liu B., Wilson B. and Hong J.-S. (2002) Microglia enhance β-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J. Neurochem. 83, 973-983.
37. Ramji D. P. and Foka P. (2002) CCAAT/enhancer-binding proteins: Structure, function and regulation. Biochem. J. 356, 561-575.
38. Saha R. N. and Pahan K. (2006) Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid. Redox Signal. 8, 929-947.
39. Sargsyan S. A., Monk P. N. and Shaw P. J. (2005) Microglia as potential contributors to motor neuron injury in amyotrophic lateral sclerosis. Glia 51, 241-253.
40. Saura J., Tusell J. M. and Serratosa J. (2003) High-yield isolation of murine microglia by mild trypsinization. Glia 44, 183-189.
41. Sekine H., Mimura J., Oshima M., Okawa H., Kanno J., Igarashi K., Gonzalez F. J., Ikuta T., Kawajiri K. and Fuji-Kuriyama Y. (2009) Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. Mol. Cell. Biol. 29, 6391-6400.
42. Suk K., Lee H., Kang S. S., Cho G. J. and Choi W. S. (2003) Flavonoid baicalein attenuates activation-induced cell death of brain microglia. J. Pharmacol. Exp. Ther. 305, 638-645.
43. Szekely C. A., Thorne J. E., Zandi P. P., Ek M., Messias E., Breitner J. C. And Goodman S. N. (2004) Nonsteroidal anti-inflammatory drugs for the prevention of Alzheimer's disease: A systematic review. Neuroepidemiology 23, 159-169.
44. Townsend K. P. and Praticò D. (2005) Novel therapeutic opportunities for Alzheimer's disease: Focus on nonsteroidal anti-inflammatory drugs. FASEB J. 19, 1592-1601. (Pubitemid 41429517)
45. Tsatsanis C., Androulidaki A., Venihaki M. and Margioris A. N. (2006) Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38, 1654-1661.
46. Vafeiadeou K., Vauzour D. and Spencer J. P. E. (2007) Neuroinflammation and its modulation by flavonoids. Endocr. Metab. Immune Disord. Drug Targets 7, 211-224.
47. Van der Heiden E., Bechoux N., Muller M., Sergent T., Schneider Y. J., Larondelle Y., Maghuin-Rogister G. and Scippo M. L. (2009) Food flavonoid aryl hydrocarbon receptor-mediated agonistic/antagonistic/ synergic activities in human and rat reporter gene assays. Anal. Chim. Acta 637, 337-345.
48. Vauzour D., Vafeidou K., Rodríguez-Mateos A., Rendeiro C. and Spencer J. P. E. (2008) The neuroprotective potential of flavonoids: A multiplicity of effects. Genes Nutr. 3, 115-126.
49. Wadleigh D. J., Reddy S. T., Kopp E., Ghosh S. and Herschman H. R. (2000) Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J. Biol. Chem. 275, 6259-6266.
50. Wang M. J., Lin W. W., Chen H. L., Chang Y. H., Ou H. C., Kuo J. S., Hong J. S. and Jeng K. C. (2002) Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur. J. Neurosci. 16, 2103-2112.
51. Whitton P. S. (2007) Inflammation as a causative factor in the aetiology of Parkinson's disease. Br. J. Pharmacol. 150, 963-976.
52. Woo K. J., Jeong Y.-J., Inoue H., Park J.-W. and Won T.-K. (2005) Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NFIL6) DNA-binding activity. FEBS Lett. 579, 705-711.
53. Woo K. J., Lim J. H., Suh S. I., Kwon Y. K., Shin S. W., Kim S. C., Choi Y. H., Park J. W. and Kwon T. K. (2006) Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPβ DNA-binding activity. Immunobiology 211, 359-368.
54. Yamada T., Tsuchiya T., Osada S., Nishihara T. and Imagawa M. (1998) CCAAT/enhancer binding-protein δ gene expression is mediated by autoregulation through downstream binding sites. Biochem. Biophys. Res. Commun. 242, 88-92.
55. Zhang S., Qin C. and Safe S. H. (2003) Flavonoids as aryl hydrocarbon receptor agonists/antagonists: Effects of structure and cell context. Environ. Health Perspect. 111, 1877-1882.
56. Zhang Y., Sif S. and De Wille J. (2007) The mouse C/EBPδ gene promoter is regulated by STAT3 and Sp1 transcriptional activators, chromatin remodeling and c-Myc repression. J. Cell. Biochem. 102, 1256-1270.
57. Zhang P., Wong T. A., Lokuta K. M., Turner D. E., Vujisic K. and Liu B. (2009) Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: Role of free radical generation. Exp. Neurol. 217, 219-230.
58. Zheng L. T., Ock J., Kwon B. M. and Suk K. (2008) Supressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int. Immunopharmacol. 8, 484-494.